{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:15:33Z","timestamp":1751602533316,"version":"3.41.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15K08673"],"award-info":[{"award-number":["15K08673"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.biopha.2018.04.041","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T18:14:06Z","timestamp":1524593646000},"page":"326-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Inhibition by non-steroidal anti-inflammatory drugs of compound action potentials in frog sciatic nerve fibers"],"prefix":"10.1016","volume":"103","author":[{"given":"Rika","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsugumi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.04.041_bib0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2018.04.041_bib0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/newbio240200a0","article-title":"Prostaglandins, aspirin-like drugs and analgesia","volume":"240","author":"Ferreira","year":"1972","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0015","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics 12th ed. McGraw-Hill","first-page":"959","article-title":"Anti-inflammatory, antipyretic, and analgesic agents; pharmacotherapy of gout","author":"Grosser","year":"2011"},{"key":"10.1016\/j.biopha.2018.04.041_bib0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.59566\/IJBS.2011.7222","article-title":"Comparison of the anti-inflammatory and analgesic effects in rats of diclofenac-sodium, felbinac and indomethacin patches","volume":"7","author":"Takayama","year":"2011","journal-title":"Int. J. Biomed. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.04.041_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/rheumatology\/35.suppl_1.1","article-title":"Introduction: mechanism of action of NSAIDs","volume":"35","author":"Vane","year":"1996","journal-title":"Brit. J. Rheumatol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0030","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1523\/JNEUROSCI.21-20-08026.2001","article-title":"Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors","volume":"21","author":"Voilley","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2018.04.041_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000338756","article-title":"Etodolac blocks the allyl isothiocyanate-induced response in mouse sensory neurons by selective TRPA1 activation","volume":"90","author":"Inoue","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopha.2018.04.041_bib0040","doi-asserted-by":"crossref","first-page":"e00232","DOI":"10.1002\/prp2.232","article-title":"Diclofenac, a nonsteroidal anti-inflammatory drug, is an antagonist of human TRPM3 isoforms","volume":"4","author":"Suzuki","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.biopha.2018.04.041_bib0045","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/mol.112.079194","article-title":"Structure-activity relationship of fenamates as Slo2.1 channel activators","volume":"82","author":"Garg","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-2999(02)01288-8","article-title":"Pharmacological evidence for the activation of K+ channels by diclofenac","volume":"438","author":"Ortiz","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0091-3057(03)00214-4","article-title":"The NO-cGMP-K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin","volume":"76","author":"Ortiz","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2018.04.041_bib0060","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.pbb.2005.05.008","article-title":"Pharmacological evidence for the activation of Ca2+-activated K+ channels by meloxicam in the formalin test","volume":"81","author":"Ortiz","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2018.04.041_bib0065","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/mol.104.007112","article-title":"Meclofenamic acid and diclofenac, novel templates of KCNQ2\/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties","volume":"67","author":"Peretz","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pharmthera.2013.01.012","article-title":"Flufenamic acid as an ion channel modulator","volume":"138","author":"Guinamard","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2018.04.041_bib0075","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.2042-7158.2012.01479.x","article-title":"Insights into the effects of diclofenac and other non-steroidal anti-inflammatory agents on ion channels","volume":"64","author":"Gwanyanya","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0080","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(97)83070-1","article-title":"The depletion of substance P by diclofenac in the mouse","volume":"325","author":"Papworth","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lfs.2015.03.011","article-title":"NSAIDs induce peripheral antinociception by interaction with the adrenergic system","volume":"130","author":"Silva","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.04.041_bib0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2016.04.029","article-title":"\u03ba-Opioid receptor participates of NSAIDs peripheral antinociception","volume":"622","author":"Silva","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2018.04.041_bib0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.brainres.2005.04.083","article-title":"Antinociception induced by intravenous dipyrone (metamizol) upon dorsal horn neurons: involvement of endogenous opioids at the periaqueductal gray matter, the nucleus raphe magnus, and the spinal cord in rats","volume":"1048","author":"Vazquez","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.04.041_bib0100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tips.2012.05.003","article-title":"NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?","volume":"33","author":"Fowler","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2018.04.041_bib0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/00003495-199141040-00003","article-title":"Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy","volume":"41","author":"McCormack","year":"1991","journal-title":"Drugs"},{"year":"1987","series-title":"Pain","author":"Fields","key":"10.1016\/j.biopha.2018.04.041_bib0110"},{"key":"10.1016\/j.biopha.2018.04.041_bib0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0706868","article-title":"Tramadol, but not its major metabolite (mono-O-demethyl tramadol) depresses compound action potentials in frog sciatic nerves","volume":"149","author":"Katsuki","year":"2006","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0120","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1476-5381.2010.00833.x","article-title":"High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without \u03b12 adrenoceptor activation","volume":"160","author":"Kosugi","year":"2010","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejphar.2017.11.047","article-title":"Compound action potential inhibition produced by various antidepressants in the frog sciatic nerve","volume":"819","author":"Hirao","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lfs.2008.06.002","article-title":"Inhibitory effects of opioids on compound action potentials in frog sciatic nerves and their chemical structures","volume":"83","author":"Mizuta","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.04.041_bib0135","doi-asserted-by":"crossref","first-page":"540238","DOI":"10.1155\/2014\/540238","article-title":"Effects of various antiepileptics used to alleviate neuropathic pain on compound action potential in frog sciatic nerves: comparison with those of local anesthetics","volume":"2014","author":"Uemura","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2018.04.041_bib0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2003.08.048","article-title":"Diclofenac inhibition of sodium currents in rat dorsal root ganglion neurons","volume":"992","author":"Lee","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.04.041_bib0145","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1167\/iovs.06-0710","article-title":"Comparative effects of the nonsteroidal anti-inflammatory drug nepafenac on corneal sensory nerve fibers responding to chemical irritation","volume":"48","author":"Acosta","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2018.04.041_bib0150","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.bbrc.2006.06.034","article-title":"The non-steroidal anti-inflammatory drug, diclofenac, inhibits Na+ current in rat myoblasts","volume":"346","author":"Fei","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.04.041_bib0155","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4196\/kjpp.2009.13.6.437","article-title":"Diclofenac, a non-steroidal anti-inflammatory drug, inhibits L-type Ca2+ channels in neonatal rat ventricular cardiomyocytes","volume":"13","author":"Yarishkin","year":"2009","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0026-895X(24)26451-8","article-title":"Inhibition of Na+ current by diphenhydramine and other diphenyl compounds: molecular determinants of selective binding to the inactivated channels","volume":"57","author":"Kuo","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1085\/jgp.200409156","article-title":"An inactivation stabilizer of the Na+ channel acts as an opportunistic pore blocker modulated by external Na+","volume":"125","author":"Yang","year":"2005","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0170","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1113\/jphysiol.2010.193037","article-title":"Flufenamic acid decreases neuronal excitability through modulation of voltage-gated sodium channel gating","volume":"588","author":"Yau","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0175","first-page":"1944","article-title":"Reduction by antiinflammatory drugs of the response of corneal sensory nerve fibers to chemical irritation","volume":"38","author":"Chen","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2018.04.041_bib0180","first-page":"145","article-title":"Bisphenol A inhibits compound action potentials in the frog sciatic nerve in a manner independent of estrogen receptors","volume":"10","author":"Mizuta","year":"2017","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.biopha.2018.04.041_bib0185","doi-asserted-by":"crossref","first-page":"e00127","DOI":"10.1002\/prp2.127","article-title":"Inhibition of the compound action potentials of frog sciatic nerves by aroma oil compounds having various chemical structures","volume":"3","author":"Ohtsubo","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.biopha.2018.04.041_bib0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1113\/jphysiol.1986.sp016095","article-title":"Long-term potentiation of transmitter release induced by adrenaline in bull-frog sympathetic ganglia","volume":"374","author":"Kuba","year":"1986","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1113\/jphysiol.1975.sp011015","article-title":"The effect of procaine on the action of acetylcholine at the neuromuscular junction","volume":"249","author":"Katz","year":"1975","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0200","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","article-title":"Local anesthetics","author":"Catterall","year":"2011"},{"key":"10.1016\/j.biopha.2018.04.041_bib0205","first-page":"101","article-title":"Acemetacin antinociceptive mechanism is not related to NO or K+ channel pathways, Methods Find","volume":"32","author":"Gil-Flores","year":"2010","journal-title":"Exp. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2018.04.041_bib0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-5793(90)80977-Q","article-title":"Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas","volume":"268","author":"G\u00f6gelein","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2018.04.041_bib0215","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00424-009-0749-9","article-title":"Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs","volume":"459","author":"Hu","year":"2010","journal-title":"Pfl\u00fcgers Arch."},{"key":"10.1016\/j.biopha.2018.04.041_bib0220","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1248\/bpb.b15-00717","article-title":"Effect of N-phenylanthranilic acid scaffold nonsteroidal anti-inflammatory drugs on the mitochondrial permeability transition","volume":"39","author":"Tatematsu","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2018.04.041_bib0225","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.lfs.2013.01.011","article-title":"Inhibition by capsaicin and its related vanilloids of compound action potentials in frog sciatic nerves","volume":"92","author":"Tomohiro","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.04.041_bib0230","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.lfs.2013.01.012","article-title":"Inhibition by menthol and its related chemicals of compound action potentials in frog sciatic nerves","volume":"92","author":"Kawasaki","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2018.04.041_bib0235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2013.02.127","article-title":"Inhibition by TRPA1 agonists of compound action potentials in the frog sciatic nerve","volume":"434","author":"Matsushita","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.04.041_bib0240","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0304-3940(93)90568-6","article-title":"C fiber generates a slow Na+ spike in the frog sciatic nerve","volume":"162","author":"Kobayashi","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2018.04.041_bib0245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pnpbp.2015.07.003","article-title":"pH-dependent inhibition of tetrodotoxin-resistant Na+ channels by diclofenac in rat nociceptive neurons","volume":"64","author":"Nakamura","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2018.04.041_bib0250","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.neuropharm.2016.02.017","article-title":"Indomethacin inhibits tetrodotoxin-resistant Na+ channels at acidic pH in rat nociceptive neurons","volume":"105","author":"Nakamura","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218303962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218303962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:29:41Z","timestamp":1751581781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218303962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":50,"alternative-id":["S0753332218303962"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.04.041","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition by non-steroidal anti-inflammatory drugs of compound action potentials in frog sciatic nerve fibers","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.04.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}